MCK,COR,COSM,HLF,NUS,CAH Stock Price and Quote

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: COR CAH HSIC CVS UNH ELV CI HUM ACH AHG

| Held by: VTI VOO IVV SPY VTV XLV VIG IWF PVAL JEPI

Index	S&P 500
Market Cap	94.36B
Enterprise Value	100.24B
Income	4.76B
Sales	403.43B
Book/sh	-18.10
Cash/sh	34.75
Dividend Est.	3.15 (0.39%)
Dividend TTM	3.28 (0.41%)
Dividend Ex-Date	Jun 01, 2026
Dividend Gr. 3/5Y	14.90% 13.68%
Payout	8.26%
Employees	43000
IPO	Nov 10, 1994

P/E	20.95
Forward P/E	16.00
PEG	1.16
P/S	0.23
P/B	-
P/C	23.20
P/FCF	16.50
EV/EBITDA	14.12
EV/Sales	0.25
Quick Ratio	0.49
Current Ratio	0.85
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	38.47
EPS next Y	50.38
EPS next Q	9.61
EPS this Y	13.09%
EPS next Y	13.90%
EPS next 5Y	13.77%
EPS past 3/5Y	15.30% -
Sales past 3/5Y	13.39% 11.11%
EPS Y/Y TTM	48.80%
Sales Y/Y TTM	12.36%
EPS Q/Q	36.97%
Sales Q/Q	6.02%
Earnings	May 07 AMC
EPS/Sales Surpr.	1.08% -4.98%

Insider Own	0.06%
Insider Trans	-32.91%
Inst Own	96.44%
Inst Trans	-0.89%
ROA	6.05%
ROE	-
ROIC	97.42%
Gross Margin	3.40%
Oper. Margin	1.58%
Profit Margin	1.18%
SMA20	3.75%
SMA50	4.79%
SMA200	-2.85%
Trades

Shs Outstand	120.00M
Shs Float	117.01M
Short Float	3.52%
Short Ratio	3.56
Short Interest	4.12M
52W High	999.00 -19.32%
52W Low	637.00 26.52%
Volatility	2.51% 2.47%
ATR (14)	20.75
RSI (14)	58.86
Beta	0.31
Rel Volume	0.43
Avg Volume	1.16M
Volume	491,646

Perf Week	2.50%
Perf Month	2.77%
Perf Quarter	-7.72%
Perf Half Y	-2.18%
Perf YTD	-1.75%
Perf Year	12.79%
Perf 3Y	94.32%
Perf 5Y	326.21%
Perf 10Y	318.05%
Recom	1.38
Target Price	940.60
Prev Close	792.81
Price	805.96
Change	1.66%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-28-26	Initiated	William Blair	Outperform
Dec-09-25	Initiated	Barclays	Overweight	$960
Dec-04-24	Resumed	Mizuho	Neutral	$630
Nov-07-24	Upgrade	Robert W. Baird	Neutral → Outperform	$531 → $688
Sep-24-24	Downgrade	Robert W. Baird	Outperform → Neutral	$603 → $531
Sep-05-24	Reiterated	Leerink Partners	Outperform	$670 → $665
Aug-08-24	Reiterated	Mizuho	Neutral	$540 → $570
Feb-26-24	Initiated	Leerink Partners	Outperform	$600
Jan-03-24	Initiated	Barclays	Overweight	$537
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$502
Mar-31-23	Initiated	Citigroup	Buy	$420
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jul-06-22	Downgrade	Argus	Buy → Hold
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$343 → $378
Apr-01-22	Resumed	Credit Suisse	Outperform	$333
Feb-04-22	Downgrade	Deutsche Bank	Buy → Hold	$262 → $270
Jan-07-22	Upgrade	Credit Suisse	Neutral → Outperform
Nov-02-21	Reiterated	Jefferies	Buy	$270 → $280
Nov-02-21	Reiterated	Evercore ISI	Outperform	$225 → $230
Nov-02-21	Reiterated	BofA Securities	Buy	$237 → $250

Show Previous Ratings

Jul-09-26 09:24AM	McKesson Stock Is Shrinking, and That's The Point for Owners (Trefis)
Jul-08-26 02:24PM	McKesson Stock Is Shrinking, And That's The Point (Trefis)
Jun-30-26 03:05AM	TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels (TMX Newsfile)
Jun-24-26 08:00AM	McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date (Business Wire)
Jun-03-26 06:54PM	McKesson Unit Prices $2.25 Billion Leveraged Loan Ahead of IPO (Bloomberg)
06:03AM	Loading…
06:03AM	Texas is the new capital of the Fortune 500taking Californias crown (Fortune)
Jun-02-26 08:00AM	McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions (Business Wire)
May-07-26 04:46PM	McKesson: Fiscal Q4 Earnings Snapshot (Associated Press)
04:10PM	McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets (Business Wire)
May-04-26 04:06PM	Trump Administration Targets Dismantling of Already-Weakened DEI (Bloomberg)
Apr-30-26 12:30AM	2 Things Matter Most in Picking Winning Stocks, Says This Market Pro (Barrons.com)
Apr-28-26 10:19AM	Micron initiated, Rambus downgraded: Wall Street's top analyst calls (The Fly)
Apr-22-26 08:00AM	McKesson Corporation Declares Quarterly Dividend (Business Wire)
Apr-20-26 12:12PM	McKesson Stock: A Compounding Engine Facing Its Critical Test (Trefis)
08:58AM	McKesson to Sell Stake of Medical-Surgical Unit to Apollo (The Wall Street Journal)
08:00AM	Loading…
08:00AM	McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions (Business Wire)
Mar-17-26 05:32AM	Cencora CFO announces retirement (Healthcare Dive)
Mar-13-26 09:55AM	Is Cardinal Health Stock Outperforming the Dow? (Barchart)
Mar-10-26 09:09PM	Bank of America Sees Upside in McKesson (MCK) Biosimilar Push, Raises Target to $1,040 (Insider Monkey)
Mar-06-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
11:26AM	3 Dividend Growth Stocks Quietly Raising Payouts (MarketBeat)
09:00AM	McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:00AM	McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences (Business Wire)
07:26AM	Is Cencora Stock Outperforming the S&P 500? (Barchart)
Mar-05-26 04:36PM	Stocks Finish Lower as War Rages in the Middle East (Barchart)
11:22AM	Stocks Fall as Crude Oil Surge Stokes Inflation Fears (Barchart)
08:10AM	McKesson Announces Planned CFO Transition (Business Wire)
Mar-04-26 06:55PM	Trump Ally Mullin Goes Stock Shopping Again: Here's His Latest Buys, Including Potential Conflict Of Interest (Benzinga)
Mar-02-26 09:36AM	Cooper Companies to Post Q1 Earnings: Is a Beat in the Offing? (Zacks)
04:31AM	Is McKesson Corporation Stock Outperforming the Nasdaq? (Barchart)
11:02PM	Loading…
Mar-01-26 11:02PM	3 Reasons We're Fans of McKesson (MCK) (StockStory)
Feb-27-26 12:45PM	Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down (Zacks)
09:40AM	Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? (Zacks)
Feb-26-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
Feb-25-26 12:51PM	Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y (Zacks)
12:49PM	Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y (Zacks)
10:30AM	Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor (Insider Monkey)
08:26AM	See How Institutional Inflows Make McKesson Fly (FX Empire)
Feb-24-26 12:31PM	Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy? (Zacks)
12:15PM	Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract (Zacks)
09:30AM	Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It? (Zacks)
08:31AM	BrightSpring to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-23-26 09:00AM	Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know (Zacks)
08:46AM	DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
08:45AM	Solventum to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-20-26 11:48AM	AMN Q4 Earnings Meet Estimates, Revenues Beat, Gross Margin Contracts (Zacks)
Feb-19-26 12:08PM	STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years (Zacks)
Feb-17-26 10:43AM	Is Wall Street Bullish or Bearish on McKesson Stock? (Barchart)
Feb-13-26 09:38AM	Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand? (Zacks)
02:11AM	Former Karaoke Company Drags Logistics Into the AI Scare Trade (Bloomberg)
Feb-11-26 02:26PM	BofA Remains Bullish on McKesson (MCK) Following Strong Third Quarter Performance (Insider Monkey)
09:40AM	Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year? (Zacks)
12:37AM	5 Insightful Analyst Questions From McKesson's Q4 Earnings Call (StockStory)
Feb-10-26 09:00AM	McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-08-26 01:29PM	McKesson's (MCK) More Powerful Than President Trump, Says Jim Cramer (Insider Monkey)
08:31AM	Trump Ally Mullin Buys 10 Stocks, Including These $5 Billion Companies You've Probably Never Heard Of (Benzinga)
Feb-06-26 10:48AM	MCK Q3 Earnings & Sales Top Estimates, 2026 View Up (Zacks)
09:45AM	Why McKesson (MCK) is a Top Growth Stock for the Long-Term (Zacks)
06:28AM	Stock Index Futures Climb After Tech Rout, Amazon Slips on CapEx Blowout (Barchart)
Feb-05-26 07:31PM	Trump Ally Mullin Buys 10 Stocks, Including These $5 Billion Companies You've Probably Never Heard Of (Benzinga) +16.52%
01:58PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
01:23PM	Stock Market Today, Feb. 5: S&P, Nasdaq fall after layoff data surprise; Alphabet details overspending (TheStreet)
01:15PM	Software's Freefall Continues, Bitcoin Dips To 16-Month Lows: What's Moving Markets Thursday? (Benzinga)
12:48PM	Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. (Barrons.com)
10:35AM	Analyst Report: McKesson Corporation (Morningstar Research)
09:30AM	McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
03:26AM	McKesson Q3 Earnings Call Highlights (MarketBeat)
01:35AM	How the Largest IPO of 2025 Could Be Healthy for Your Portfolio (Motley Fool)
12:41AM	MCK Q4 Deep Dive: Oncology, Tech Investments, and Portfolio Focus Drive Growth (StockStory)
12:04AM	McKesson Corp (MCK) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance (GuruFocus.com)
Feb-04-26 11:42PM	Analyst Report: McKesson Corporation (Morningstar Research)
06:05PM	McKesson (MCK) Q3 2026 Earnings Call Transcript (Motley Fool)
06:00PM	McKesson (MCK) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	McKesson (MCK) Q3 Earnings and Revenues Top Estimates (Zacks)
05:03PM	McKesson (NYSE:MCK) Reports Q4 CY2025 In Line With Expectations (StockStory)
04:19PM	McKesson: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance (Business Wire)
01:44PM	Analyst Report: Cencora, Inc. (Morningstar Research)
Feb-03-26 09:28AM	Should You Buy, Sell, or Hold McKesson Before Q3 Earnings? (Zacks)
07:24AM	Jim Cramer on McKesson: "When This Company Reports, Its Stock Usually Flies" (Insider Monkey)
Feb-02-26 10:08PM	Earnings To Watch: McKesson (MCK) Reports Q4 Results Tomorrow (StockStory)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 05:50PM	Why the Market Dipped But McKesson (MCK) Gained Today (Zacks)
09:15AM	Unlocking Q3 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics (Zacks)
08:00AM	McKesson Corporation Completes Divestiture of Norwegian Operations (Business Wire)
Jan-28-26 08:00AM	McKesson Corporation Declares Quarterly Dividend (Business Wire)
Jan-27-26 08:09PM	Analyst Report: Cencora, Inc. (Morningstar Research)
Jan-26-26 01:27PM	IBD Stock Of The Day: Why Cardinal Health's Momentum Is 'Special' And Not Over Yet (Investor's Business Daily)
09:40AM	Why McKesson (MCK) is a Top Value Stock for the Long-Term (Zacks)
Jan-23-26 03:58AM	Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology (Zacks)
Jan-22-26 09:09AM	4 Medical Supply Stocks Poised to Gain in a Prospering Industry (Zacks)
Jan-21-26 09:00AM	McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:09AM	As risk skyrockets, current and former CFOs are in demand for audit committees (Fortune)
Jan-20-26 06:00PM	McKesson (MCK) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Jan-16-26 12:45PM	McKesson (MCK) is a Stock That "Defies The President," Says Jim Cramer (Insider Monkey)
09:40AM	Are Investors Undervaluing McKesson (MCK) Right Now? (Zacks)
09:15AM	Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jan-14-26 06:00PM	McKesson (MCK) Advances While Market Declines: Some Information for Investors (Zacks)
Jan-12-26 07:51AM	3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds (Zacks)
Jan-09-26 09:40AM	Why McKesson (MCK) is a Top Value Stock for the Long-Term (Zacks)

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

CEO & ChairmanMr. Brian S. Tyler Ph.D.

Executive VP & Chief Legal OfficerMs. Michele Lau J.D.

Executive VP & Chief Human Resources OfficerMs. LeAnn B. Smith

Executive OfficerMr. Britt J. Vitalone CPA

Executive VP and Chief Strategy & Business Development OfficerMr. Thomas L. Rodgers M.B.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TYLER BRIAN S.	Chief Executive Officer	Jul 07 '26	Sale	793.56	8,463	6,715,898	5,919	Jul 08 04:25 PM
TYLER BRIAN S.	Officer	Jul 07 '26	Proposed Sale	793.56	8,463	6,715,898		Jul 07 09:46 AM
TYLER BRIAN S.	Chief Executive Officer	Jun 17 '26	Sale	775.13	8,463	6,559,925	14,382	Jun 18 03:35 PM
TYLER BRIAN S.	Officer	Jun 17 '26	Proposed Sale	775.13	8,463	6,559,925		Jun 17 10:05 AM
TYLER BRIAN S.	Chief Executive Officer	Jun 09 '26	Sale	763.00	4,929	3,760,827	22,845	Jun 11 10:30 AM
TYLER BRIAN S.	Officer	Jun 09 '26	Proposed Sale	763.00	4,929	3,760,827		Jun 09 10:03 AM
Rutledge Napoleon B JR	SVP, Controller & CAO	Jun 05 '26	Sale	764.00	133	101,612	632	Jun 08 02:54 PM
Rodgers Thomas L	EVP, Chief Strategy & BDO	Jun 02 '26	Sale	735.27	699	513,954	2,268	Jun 03 11:00 AM
Rodgers Thomas L	EVP, Chief Strategy & BDO	Jun 01 '26	Sale	735.50	123	90,466	2,967	Jun 03 11:00 AM
Smith LeAnn B	EVP & Chief HR Officer	Jun 01 '26	Sale	735.50	1,810	1,331,255	4,798	Jun 02 03:27 PM
Rodgers Thomas L	Officer	Jun 02 '26	Proposed Sale	735.27	699	513,954		Jun 02 10:23 AM
Rodgers Thomas L	Officer	Jun 01 '26	Proposed Sale	735.50	123	90,466		Jun 01 12:10 PM
Smith LeAnn B	Officer	Jun 01 '26	Proposed Sale	735.50	1,810	1,331,255		Jun 01 11:23 AM
Lau Michele	EVP and Chief Legal Officer	May 26 '26	Sale	761.09	3,550	2,701,870	3,247	May 27 02:14 PM
TYLER BRIAN S.	Chief Executive Officer	May 23 '26	Option Exercise	0.00	4,579	0	29,605	May 27 02:13 PM
Vitalone Britt J.	EVP & CFO	May 23 '26	Option Exercise	0.00	1,476	0	22,534	May 27 02:13 PM
Smith LeAnn B	EVP & Chief HR Officer	May 23 '26	Option Exercise	0.00	679	0	6,876	May 27 02:13 PM
Rodgers Thomas L	EVP, Chief Strategy & BDO	May 23 '26	Option Exercise	0.00	594	0	5,712	May 27 02:12 PM
Rodgers Thomas L	EVP, Chief Strategy & BDO	May 26 '26	Sale	761.09	2,388	1,817,483	3,090	May 27 02:12 PM
Rutledge Napoleon B JR	SVP, Controller & CAO	May 23 '26	Option Exercise	0.00	136	0	806	May 27 02:12 PM
Fraga Francisco	EVP, CIO and CTO	May 23 '26	Option Exercise	0.00	136	0	6,264	May 27 02:12 PM
TYLER BRIAN S.	Chief Executive Officer	May 21 '26	Option Exercise	0.00	3,500	0	26,345	May 26 02:24 PM
Vitalone Britt J.	EVP & CFO	May 21 '26	Option Exercise	0.00	1,207	0	21,505	May 26 02:24 PM
Smith LeAnn B	EVP & Chief HR Officer	May 21 '26	Option Exercise	0.00	531	0	6,406	May 26 02:23 PM
Rodgers Thomas L	EVP, Chief Strategy & BDO	May 21 '26	Option Exercise	0.00	423	0	5,275	May 26 02:23 PM
Rutledge Napoleon B JR	SVP, Controller & CAO	May 21 '26	Option Exercise	0.00	91	0	697	May 26 02:23 PM
Lau Michele	EVP and Chief Legal Officer	May 21 '26	Option Exercise	0.00	724	0	7,082	May 26 02:22 PM
Fraga Francisco	EVP, CIO and CTO	May 21 '26	Option Exercise	0.00	483	0	6,319	May 26 02:22 PM
Lau Michele	Officer	May 26 '26	Proposed Sale	761.09	3,550	2,701,870		May 26 10:04 AM
Rodgers Thomas L	Officer	May 26 '26	Proposed Sale	761.09	2,388	1,817,483		May 26 09:42 AM
Fraga Francisco	EVP, CIO and CTO	May 20 '26	Option Exercise	0.00	463	0	6,019	May 22 05:55 PM
Lau Michele	EVP and Chief Legal Officer	May 20 '26	Option Exercise	0.00	677	0	6,625	May 22 05:54 PM
Rutledge Napoleon B JR	SVP, Controller & CAO	May 20 '26	Option Exercise	0.00	74	0	628	May 22 05:54 PM
Rodgers Thomas L	EVP, Chief Strategy & BDO	May 20 '26	Option Exercise	0.00	324	0	4,980	May 22 05:54 PM
Smith LeAnn B	EVP & Chief HR Officer	May 20 '26	Option Exercise	0.00	463	0	6,058	May 22 05:53 PM
Vitalone Britt J.	EVP & CFO	May 20 '26	Option Exercise	0.00	1,038	0	20,707	May 22 05:53 PM
TYLER BRIAN S.	Chief Executive Officer	May 20 '26	Option Exercise	0.00	3,189	0	24,127	May 22 05:52 PM
Lau Michele	EVP and Chief Legal Officer	Mar 02 '26	Sale	990.00	2,725	2,697,750	3,247	Mar 04 12:41 PM
Lau Michele	Officer	Mar 02 '26	Proposed Sale	990.00	2,725	2,697,750		Mar 02 02:21 PM
Martinez Maria	Director	Feb 19 '26	Sale	939.87	349	328,013	301	Feb 23 01:13 PM
Martinez Maria	Director	Feb 19 '26	Proposed Sale	939.87	349	328,013		Feb 19 03:55 PM
Smith LeAnn B	EVP & Chief HR Officer	Feb 17 '26	Sale	945.00	190	179,550	2,989	Feb 18 07:04 PM
Smith LeAnn B	Officer	Feb 17 '26	Proposed Sale	945.00	190	179,550		Feb 17 02:27 PM
Lau Michele	EVP and Chief Legal Officer	Feb 11 '26	Sale	933.39	303	282,817	5,972	Feb 13 03:26 PM
Smith LeAnn B	EVP & Chief HR Officer	Feb 10 '26	Option Exercise	0.00	508	0	3,308	Feb 12 06:20 PM
Lau Michele	EVP and Chief Legal Officer	Feb 09 '26	Option Exercise	0.00	4,748	0	7,237	Feb 11 03:25 PM
Lau Michele	Officer	Feb 11 '26	Proposed Sale	933.39	303	282,817		Feb 11 09:51 AM
Rutledge Napoleon B JR	SVP, Controller & CAO	Feb 06 '26	Sale	955.00	328	313,240	0	Feb 09 05:30 PM
Rodgers Thomas L	EVP, Chief Strategy & BDO	Jan 05 '26	Sale	816.18	276	225,266	2,268	Jan 06 02:26 PM
Rodgers Thomas L	Officer	Jan 05 '26	Proposed Sale	816.18	276	225,266		Jan 05 10:47 AM
Rutledge Napoleon B JR	SVP, Controller & CAO	Nov 07 '25	Sale	861.63	329	283,476	328	Nov 10 02:45 PM
TYLER BRIAN S.	Chief Executive Officer	Aug 22 '25	Sale	705.63	11,930	8,418,166	4,012	Aug 25 04:30 PM
TYLER BRIAN S.	Officer	Aug 22 '25	Proposed Sale	705.63	11,930	8,418,166		Aug 22 09:44 AM
TYLER BRIAN S.	Chief Executive Officer	Aug 15 '25	Sale	677.76	11,930	8,085,677	15,942	Aug 19 10:20 AM
TYLER BRIAN S.	Officer	Aug 15 '25	Proposed Sale	677.76	11,930	8,085,677		Aug 15 09:52 AM
Rutledge Napoleon B JR	SVP, Controller & CAO	Aug 08 '25	Sale	663.67	329	218,347	657	Aug 11 04:52 PM

Peers: CAH MCK MDLN HSIC CVS UNH CI ELV HUM AHG

| Held by: VTI VOO VO IVV SPY VTV XLV IWP VOE VIG

Index	S&P 500
Market Cap	59.04B
Enterprise Value	69.37B
Income	2.55B
Sales	328.68B
Book/sh	17.46
Cash/sh	11.49
Dividend Est.	2.37 (0.78%)
Dividend TTM	2.35 (0.77%)
Dividend Ex-Date	May 15, 2026
Dividend Gr. 3/5Y	6.14% 5.79%
Payout	27.63%
Employees	51000
IPO	Apr 04, 1995

P/E	23.28
Forward P/E	15.31
PEG	1.36
P/S	0.18
P/B	17.38
P/C	26.40
P/FCF	37.89
EV/EBITDA	13.27
EV/Sales	0.21
Quick Ratio	0.59
Current Ratio	0.95
Debt/Eq	3.65
LT Debt/Eq	3.59
Option/Short	Yes / Yes

EPS (ttm)	13.03
EPS next Y	19.82
EPS next Q	4.34
EPS this Y	11.14%
EPS next Y	11.44%
EPS next 5Y	11.25%
EPS past 3/5Y	-0.34% -
Sales past 3/5Y	10.43% 11.09%
EPS Y/Y TTM	51.04%
Sales Y/Y TTM	5.95%
EPS Q/Q	128.30%
Sales Q/Q	3.85%
Earnings	May 06 BMO
EPS/Sales Surpr.	-1.42% -3.37%

Insider Own	0.49%
Insider Trans	-0.17%
Inst Own	99.37%
Inst Trans	0.50%
ROA	3.33%
ROE	115.58%
ROIC	16.36%
Gross Margin	3.46%
Oper. Margin	1.27%
Profit Margin	0.78%
SMA20	5.49%
SMA50	8.90%
SMA200	-6.53%
Trades

Shs Outstand	194.56M
Shs Float	193.61M
Short Float	2.84%
Short Ratio	3.02
Short Interest	5.50M
52W High	377.54 -19.63%
52W Low	244.82 23.94%
Volatility	2.44% 2.42%
ATR (14)	7.57
RSI (14)	65.26
Beta	0.57
Rel Volume	0.40
Avg Volume	1.82M
Volume	727,334

Perf Week	2.34%
Perf Month	8.54%
Perf Quarter	-5.90%
Perf Half Y	-10.86%
Perf YTD	-10.16%
Perf Year	2.06%
Perf 3Y	57.36%
Perf 5Y	163.56%
Perf 10Y	270.41%
Recom	1.61
Target Price	353.50
Prev Close	302.46
Price	303.44
Change	0.32%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-28-26	Initiated	William Blair	Mkt Perform
Jan-29-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$400
Jan-22-26	Upgrade	Jefferies	Hold → Buy	$440
Dec-09-25	Initiated	Barclays	Overweight	$400
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform

Show Previous Ratings

Jul-09-26 09:24AM	McKesson Stock Is Shrinking, and That's The Point for Owners (Trefis)
Jul-08-26 02:24PM	McKesson Stock Is Shrinking, And That's The Point (Trefis)
Jul-01-26 04:30PM	Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release (Business Wire)
Jun-15-26 04:15PM	Cencora Announces Samantha Hammock as Chief Human Resources Officer (Business Wire)
May-27-26 07:14AM	Cencora nabs ex-CVS exec as new CFO (Healthcare Dive)
06:55AM	Loading…
06:55AM	Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer (Business Wire)
May-21-26 04:30PM	Cencora Announces Updated Fiscal Year 2026 Financial Outlook (Business Wire)
May-06-26 12:48PM	Cencora, Inc. Q2 2026 Earnings Call Summary (Moby) -17.38%
06:48AM	Cencora: Fiscal Q2 Earnings Snapshot (Associated Press)
06:30AM	Cencora Reports Fiscal 2026 Second Quarter Results (Business Wire)
Apr-30-26 12:30AM	2 Things Matter Most in Picking Winning Stocks, Says This Market Pro (Barrons.com)
Apr-20-26 12:12PM	McKesson Stock: A Compounding Engine Facing Its Critical Test (Trefis)
Apr-01-26 04:30PM	Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release (Business Wire)
Mar-24-26 05:19AM	Cencora to buy EyeSouths retina business for $1.1B (Healthcare Dive)
Mar-23-26 07:00AM	Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners Retina Business (Business Wire)
04:36PM	Loading…
Mar-17-26 04:36PM	Stock Indexes Advance as Chip Makers and Travel Stocks Rally (Barchart)
11:17AM	Stocks Climb on Strength in Chip and Travel Stocks (Barchart)
10:15AM	Stocks Supported by Lower Bond Yields (Barchart)
08:30AM	Cencora Announces Financial Leadership Transition (Business Wire)
05:32AM	Cencora CFO announces retirement (Healthcare Dive)
Mar-13-26 04:41PM	How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro (Investor's Business Daily)
Mar-06-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
11:30AM	Why Is Cencora (COR) Up 2% Since Last Earnings Report? (Zacks)
07:26AM	Is Cencora Stock Outperforming the S&P 500? (Barchart)
Mar-02-26 04:31AM	Is McKesson Corporation Stock Outperforming the Nasdaq? (Barchart)
Feb-26-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
Feb-19-26 07:56AM	COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal (Zacks)
Feb-18-26 07:00AM	Covetrus and MWI Animal Health to Merge (Business Wire)
Feb-17-26 08:52AM	Is the Options Market Predicting a Spike in Cencora Stock? (Zacks)
Feb-13-26 04:15PM	Cencora Closes $3.0 Billion Senior Notes Offering (Business Wire)
03:51PM	Loading…
03:51PM	Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know (StockStory)
Feb-11-26 11:37PM	1 Momentum Stock with Impressive Fundamentals and 2 We Question (StockStory)
12:36AM	5 Revealing Analyst Questions From Cencora's Q4 Earnings Call (StockStory)
Feb-10-26 05:15PM	Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 (Business Wire)
07:31AM	What Are Wall Street Analysts' Target Price for Cencora Stock? (Barchart)
Feb-06-26 09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
Feb-05-26 03:31PM	Cencora (COR) Stock Trades Up, Here Is Why (StockStory) +6.72%
01:58PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
12:48PM	Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. (Barrons.com)
10:35AM	Analyst Report: McKesson Corporation (Morningstar Research)
01:13AM	Cencora Q1 Earnings Call Highlights (MarketBeat)
12:34AM	COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts (StockStory)
Feb-04-26 11:42PM	Analyst Report: McKesson Corporation (Morningstar Research) -8.79%
04:05PM	Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges (GuruFocus.com)
01:44PM	Analyst Report: Cencora, Inc. (Morningstar Research)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:32AM	Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss (Benzinga)
11:12AM	Rotation out of Tech Stocks Weighs on the Broader Market (Barchart)
10:04AM	Cencora (COR) Q1 2026 Earnings Call Transcript (Motley Fool)
10:03AM	Stocks Mixed on Sector Rotation out of Tech (Barchart)
09:30AM	Cencora (COR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:40AM	Cencora (COR) Q1 Earnings Top Estimates (Zacks)
06:47AM	Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates (StockStory)
06:38AM	Cencora: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2026 First Quarter Results (Business Wire)
Feb-02-26 10:06PM	Cencora (COR) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 09:36AM	Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)'s Growth Story Gains Momentum (Insider Monkey)
Jan-30-26 09:15AM	Exploring Analyst Estimates for Cencora (COR) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-26 09:35AM	First Solar downgraded, Fortinet upgraded: Wall Street's top analyst calls (The Fly)
08:33AM	Can Specialty and International Momentum Support Cencora's Q1 Results? (Zacks)
Jan-27-26 08:09PM	Analyst Report: Cencora, Inc. (Morningstar Research)
Jan-26-26 01:27PM	IBD Stock Of The Day: Why Cardinal Health's Momentum Is 'Special' And Not Over Yet (Investor's Business Daily)
Jan-25-26 04:46AM	Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI (Investing.com)
Jan-22-26 07:30AM	Cencora Elects Ellen Cooper to Its Board of Directors (Business Wire)
Jan-12-26 07:51AM	3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds (Zacks)
Jan-09-26 09:06AM	What to Expect From Cencora's Next Quarterly Earnings Report (Barchart)
Jan-08-26 08:40PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
07:57AM	Here's Why You Should Retain Cencora Stock in Your Portfolio Now (Zacks)
Jan-07-26 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Jan-06-26 04:30PM	Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release (Business Wire)
Jan-05-26 01:44PM	McKesson Builds Earnings Momentum on Specialty and Automation (Zacks)
Dec-30-25 07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
Dec-29-25 10:17AM	Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus (Zacks)
08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-26-25 07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
Dec-24-25 10:36PM	Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks (StockStory)
09:11AM	These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026 (Zacks)
Dec-23-25 02:09PM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
09:35AM	Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora (Zacks)
Dec-22-25 10:40AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
Dec-19-25 02:14PM	Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" (Insider Monkey)
11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks)
Dec-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-17-25 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-16-25 03:52AM	Cencora takes majority stake in cancer care platform OneOncology for $5B (Healthcare Dive)
Dec-15-25 08:01PM	Lightning Round: Sell BP, says Jim Cramer (CNBC TV)
02:50PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:06AM	Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus (Zacks)
07:00AM	Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology (Business Wire)
Dec-10-25 08:59AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
Dec-09-25 09:40AM	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-05-25 11:30AM	Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? (Zacks)
Dec-03-25 03:26PM	Why Cencora (COR) Shares Are Trading Lower Today (StockStory)
02:59PM	JPMorgan Raises Cencora (COR) Price Target After Financial Model Update (Insider Monkey)
03:35AM	How Is Cencoras Stock Performance Compared to Other Medical Stocks? (Barchart)
Dec-02-25 12:00PM	Cencora (COR) Upgraded to Buy: Here's Why (Zacks)
09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Dec-01-25 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

PharmDDr. Robert P. Mauch Ph.D.

Executive VP & CFOMr. James F. Cleary Jr.

Executive VP & Chief Legal OfficerMs. Elizabeth S. Campbell J.D.

Executive VP & Chief Human Resources OfficerMs. Silvana Battaglia

Senior VPMr. Lazarus Krikorian

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tyler Lauren M	Director	Jun 22 '26	Buy	270.23	550	148,626	4,359	Jun 24 04:04 PM
DURCAN DERMOT MARK	Director	Jun 18 '26	Buy	274.19	4,000	1,096,760	31,767	Jun 22 04:05 PM
DURCAN DERMOT MARK	Director	May 28 '26	Buy	266.26	4,000	1,065,040	27,767	May 28 04:23 PM
Battaglia Silvana	Executive Vice President	Mar 11 '26	Option Exercise	0.00	8,415	0	27,239	Mar 13 04:17 PM
Campbell Elizabeth S	Executive Vice President	Mar 11 '26	Option Exercise	0.00	12,623	0	36,548	Mar 13 04:16 PM
Cleary James F	Chief Financial Officer	Mar 11 '26	Option Exercise	0.00	12,623	0	165,766	Mar 13 04:14 PM
Mauch Robert P.	President & CEO	Feb 20 '26	Option Exercise	86.09	3,762	323,871	69,155	Feb 24 04:04 PM
Mauch Robert P.	President & CEO	Feb 20 '26	Sale	358.94	3,762	1,350,332	65,393	Feb 24 04:04 PM
Mauch Robert P.	President & CEO	Feb 18 '26	Sale	359.46	1,333	479,160	65,393	Feb 20 04:00 PM
Mauch Robert P.	Officer	Feb 20 '26	Proposed Sale	358.94	3,762	1,350,332		Feb 20 12:27 PM
Mauch Robert P.	Officer	Feb 18 '26	Proposed Sale	359.46	1,333	479,160		Feb 18 11:03 AM
Mauch Robert P.	President & CEO	Jan 20 '26	Option Exercise	86.09	3,763	323,957	71,822	Jan 22 04:43 PM
Mauch Robert P.	President & CEO	Jan 20 '26	Sale	354.73	5,096	1,807,704	66,726	Jan 22 04:43 PM
Mauch Robert P.	Officer	Jan 20 '26	Proposed Sale	354.73	5,096	1,807,704		Jan 20 11:14 AM
Battaglia Silvana	Executive Vice President	Dec 19 '25	Sale	345.00	1,677	578,565	18,796	Dec 22 04:15 PM
Campbell Elizabeth S	Executive Vice President	Dec 19 '25	Sale	342.10	3,351	1,146,377	23,891	Dec 22 04:15 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Option Exercise	86.09	3,763	323,957	73,155	Dec 22 04:14 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Sale	343.45	5,096	1,750,221	68,059	Dec 22 04:14 PM
Campbell Elizabeth S	Officer	Dec 19 '25	Proposed Sale	342.10	3,351	1,146,377		Dec 19 04:15 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 17 '25	Sale	343.24	4,031	1,383,580	17,154	Dec 19 04:04 PM
Cleary James F	Chief Financial Officer	Dec 17 '25	Option Exercise	86.09	45,154	3,887,308	180,095	Dec 19 04:03 PM
Battaglia Silvana	Officer	Dec 19 '25	Proposed Sale	345.00	1,677	578,565		Dec 19 11:03 AM
Mauch Robert P.	Officer	Dec 18 '25	Proposed Sale	343.45	5,096	1,750,221		Dec 18 09:48 AM
Krikorian Lazarus	Officer	Dec 17 '25	Proposed Sale	343.24	4,031	1,383,580		Dec 17 03:55 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Option Exercise	86.09	3,763	323,957	70,842	Nov 19 05:09 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Sale	366.64	5,096	1,868,397	65,746	Nov 19 05:09 PM
Mauch Robert P.	Officer	Nov 18 '25	Proposed Sale	366.64	5,096	1,868,397		Nov 18 11:43 AM
COLLIS STEVEN H	Former Officer & Director	Nov 18 '25	Proposed Sale	366.64	31,349	11,493,797		Nov 18 10:40 AM
COLLIS STEVEN H	Former Officer & Director	Nov 06 '25	Proposed Sale	355.25	50,000	17,762,554		Nov 06 04:16 PM
Verma Pawan	EVP, Chief Data & Info Officer	Oct 31 '25	Option Exercise	337.81	8,537	2,883,884	8,551	Nov 04 04:15 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Option Exercise	86.09	3,763	323,957	43,037	Oct 21 04:33 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Sale	326.80	5,097	1,665,700	37,940	Oct 21 04:33 PM
COLLIS STEVEN H	Former Officer & Director	Oct 21 '25	Proposed Sale	326.99	31,350	10,251,105		Oct 21 04:16 PM
Mauch Robert P.	Officer	Oct 20 '25	Proposed Sale	326.80	5,097	1,665,700		Oct 20 09:36 AM
Campbell Elizabeth S	Executive Vice President	Oct 01 '25	Sale	313.28	1,886	590,846	12,824	Oct 03 04:01 PM
Campbell Elizabeth S	Officer	Oct 01 '25	Proposed Sale	313.28	1,886	590,846		Oct 01 10:36 AM
Mauch Robert P.	President & CEO	Sep 18 '25	Option Exercise	86.09	3,763	323,957	44,371	Sep 22 04:16 PM
Mauch Robert P.	President & CEO	Sep 18 '25	Sale	290.00	5,097	1,478,130	39,274	Sep 22 04:16 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Option Exercise	86.09	29,350	2,526,742	337,263	Sep 18 03:56 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Sale	289.86	31,350	9,087,142	305,913	Sep 18 03:56 PM
Mauch Robert P.	Officer	Sep 18 '25	Proposed Sale	290.00	5,097	1,478,130		Sep 18 11:54 AM
COLLIS STEVEN H	Director	Sep 16 '25	Proposed Sale	291.55	31,350	9,140,092		Sep 16 10:27 AM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Option Exercise	86.09	12,579	1,082,926	322,492	Aug 20 04:08 PM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Sale	289.98	14,579	4,227,618	307,913	Aug 20 04:08 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Option Exercise	86.09	3,225	277,640	45,576	Aug 20 04:06 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Sale	293.53	4,968	1,458,257	40,608	Aug 20 04:06 PM
COLLIS STEVEN H	Director	Aug 19 '25	Proposed Sale	289.98	14,579	4,227,618		Aug 19 09:51 AM
Mauch Robert P.	Officer	Aug 18 '25	Proposed Sale	293.53	4,968	1,458,257		Aug 18 11:06 AM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Option Exercise	86.09	12,578	1,082,840	324,491	Jul 23 04:30 PM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Sale	292.67	14,578	4,266,543	309,913	Jul 23 04:30 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Option Exercise	86.09	3,225	277,640	47,319	Jul 22 04:23 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Sale	294.11	4,968	1,461,138	42,351	Jul 22 04:23 PM
COLLIS STEVEN H	Director	Jul 22 '25	Proposed Sale	292.67	14,578	4,266,543		Jul 22 09:47 AM
Mauch Robert P.	Officer	Jul 18 '25	Proposed Sale	294.11	4,968	1,461,138		Jul 18 11:44 AM

COSM Cosmos Health Inc daily Stock Chart

Peers: YI ACH FOCL HSIC COR MCK EVH HCAT VEEV PFGC

| Held by: VXF

Index	-
Market Cap	18.17M
Enterprise Value	34.46M
Income	-21.13M
Sales	69.49M
Book/sh	0.40
Cash/sh	0.04
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	163
IPO	Jul 23, 2010

P/E	-
Forward P/E	4.18
PEG	-
P/S	0.26
P/B	0.73
P/C	8.30
P/FCF	-
EV/EBITDA	-
EV/Sales	0.50
Quick Ratio	0.92
Current Ratio	1.08
Debt/Eq	0.93
LT Debt/Eq	0.33
Option/Short	Yes / Yes

EPS (ttm)	-0.65
EPS next Y	0.07
EPS next Q	0.01
EPS this Y	101.59%
EPS next Y	600.00%
EPS next 5Y	-
EPS past 3/5Y	73.29% -
Sales past 3/5Y	9.04% 3.33%
EPS Y/Y TTM	37.35%
Sales Y/Y TTM	29.75%
EPS Q/Q	-89.81%
Sales Q/Q	30.74%
Earnings	May 21 BMO
EPS/Sales Surpr.	0.00% -0.16%

Insider Own	32.85%
Insider Trans	16.04%
Inst Own	2.37%
Inst Trans	-0.71%
ROA	-35.35%
ROE	-92.33%
ROIC	-80.00%
Gross Margin	8.39%
Oper. Margin	-25.75%
Profit Margin	-30.41%
SMA20	30.46%
SMA50	10.64%
SMA200	-41.18%
Trades

Shs Outstand	49.78M
Shs Float	41.69M
Short Float	11.38%
Short Ratio	0.57
Short Interest	4.74M
52W High	1.32 -77.83%
52W Low	0.16 81.13%
Volatility	22.17% 19.33%
ATR (14)	0.04
RSI (14)	63.36
Beta	4.16
Rel Volume	2.48
Avg Volume	8.26M
Volume	20,471,316

Perf Week	23.45%
Perf Month	31.08%
Perf Quarter	0.93%
Perf Half Y	-43.77%
Perf YTD	-41.22%
Perf Year	-36.78%
Perf 3Y	-90.71%
Perf 5Y	-99.78%
Perf 10Y	-99.80%
Recom	1.00
Target Price	4.50
Prev Close	0.26
Price	0.29
Change	12.02%

Jul-10-26 10:55AM	Cosmos Health Launches Subscription Model (GlobeNewswire) +12.02%
Jul-09-26 03:45PM	Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases (GlobeNewswire)
Jul-08-26 03:40PM	Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases (GlobeNewswire)
Jul-07-26 02:27PM	Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases (GlobeNewswire)
09:29AM	Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases (GlobeNewswire)
02:30PM	Loading…
Jul-06-26 02:30PM	Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases (GlobeNewswire) +13.83%
Jul-02-26 02:10PM	Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases (GlobeNewswire) +17.61%
Jul-01-26 11:05AM	Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace (GlobeNewswire) +9.15%
01:06AM	Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? (Stocktwits)
Jun-30-26 11:55AM	Cosmos Health Authorizes Up to $5 Million Share Repurchase Program (GlobeNewswire) +5.54%
Jun-26-26 01:32PM	This Nano Cap Company Tapped A Key Distribution Partner In Qatar CEO Calls It High-Impact Partnership (Stocktwits) -7.07%
12:30PM	Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units (GlobeNewswire)
Jun-25-26 03:31PM	Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada (GlobeNewswire) -10.91%
Jun-24-26 03:37PM	Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin (GlobeNewswire)
Jun-23-26 03:35PM	Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency (GlobeNewswire)
10:30AM	Loading…
Jun-22-26 10:30AM	Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit (GlobeNewswire)
Jun-18-26 03:34PM	CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity (GlobeNewswire) -11.92%
Jun-17-26 03:35PM	Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States (GlobeNewswire)
09:27AM	Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products (GlobeNewswire)
Jun-15-26 09:00AM	Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit (GlobeNewswire) +12.90%
Jun-12-26 03:33PM	Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines (GlobeNewswire)
09:29AM	Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit (GlobeNewswire)
Jun-11-26 03:31PM	Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio (GlobeNewswire) -9.69%
09:35AM	Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance (GlobeNewswire)
Jun-10-26 03:32PM	Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries (GlobeNewswire)
09:00AM	Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform - Record Growth with U.S. Expansion Underway (GlobeNewswire)
Jun-09-26 03:30PM	Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN (GlobeNewswire)
Jun-08-26 10:00AM	Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives (GlobeNewswire) -8.29%
Jun-05-26 09:25AM	Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories (GlobeNewswire) -7.42%
Jun-04-26 03:57PM	Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz (GlobeNewswire) +9.81%
09:25AM	Loading…
09:25AM	Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value (GlobeNewswire)
Jun-02-26 08:00AM	Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to 25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline (GlobeNewswire)
Jun-01-26 12:16PM	Cosmos Health enters animal health market with C-Scrub brand (Proactive)
08:25AM	Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657 (GlobeNewswire)
May-26-26 09:34AM	Cosmos Health Releases 2026-2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 - Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation (GlobeNewswire)
May-21-26 02:20PM	Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants (ACCESSWIRE) -10.20%
09:15AM	Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway (ACCESSWIRE)
May-14-26 09:00AM	Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its 50M R&D Program; EIB Financing Represents up to 50%, or 25M, under the EIB's Venture Debt Program (ACCESSWIRE)
May-12-26 10:15AM	Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 (ACCESSWIRE)
May-11-26 02:25PM	Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months (ACCESSWIRE) -7.64%
May-08-26 11:25AM	Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed (ACCESSWIRE) -5.06%
May-06-26 10:35AM	Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness (ACCESSWIRE)
Apr-30-26 12:50PM	Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months (ACCESSWIRE)
Apr-21-26 12:50PM	Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products (ACCESSWIRE) -9.10%
Apr-20-26 10:55AM	Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio (ACCESSWIRE) -5.59%
Apr-17-26 02:00PM	Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39x Higher Bioavailability and Designed to Support Joint Health (ACCESSWIRE)
Apr-16-26 03:15PM	Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% (ACCESSWIRE)
Apr-15-26 09:25AM	Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments (ACCESSWIRE) +16.92%
Apr-13-26 12:50PM	Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units (ACCESSWIRE) +8.50%
Apr-10-26 09:40AM	Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months (ACCESSWIRE)
Apr-08-26 11:10AM	Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction (ACCESSWIRE)
Apr-01-26 11:42AM	Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets (ACCESSWIRE)
Mar-19-26 12:45PM	Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions (GlobeNewswire)
Mar-11-26 01:45PM	Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000 (GlobeNewswire)
Mar-10-26 09:00AM	Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000 (GlobeNewswire) -6.02%
Feb-24-26 12:30PM	Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board (GlobeNewswire)
Feb-19-26 11:30AM	Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value (GlobeNewswire) -5.88%
Feb-18-26 01:45PM	Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer (GlobeNewswire) +9.53%
10:17AM	Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer (GlobeNewswire)
Feb-17-26 11:25AM	Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026 (GlobeNewswire)
Feb-11-26 12:10PM	Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies (GlobeNewswire)
Jan-20-26 10:45AM	Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue (GlobeNewswire) -5.57%
Jan-14-26 11:25AM	Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research (GlobeNewswire)
Jan-05-26 09:30AM	Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units (GlobeNewswire)
Dec-24-25 09:00AM	Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy (ACCESSWIRE)
Dec-19-25 09:00AM	Cosmos Health is Forcing the Market to Reframe the Conversation (ACCESSWIRE)
Dec-03-25 12:20PM	Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets (GlobeNewswire) -10.81%
Dec-02-25 12:15PM	Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases (GlobeNewswire)
Nov-17-25 09:15AM	Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M (GlobeNewswire)
Oct-31-25 10:45AM	Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy (GlobeNewswire) -10.01%
Oct-21-25 12:10PM	Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million (GlobeNewswire)
Oct-16-25 08:00AM	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) -12.80%
Oct-13-25 02:05PM	Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million (GlobeNewswire)
Oct-10-25 08:00AM	Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility (GlobeNewswire)
Oct-03-25 03:56PM	Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units (GlobeNewswire)
Sep-29-25 08:00AM	Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation (GlobeNewswire)
Sep-25-25 08:00AM	Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL Pessaries Annually (GlobeNewswire)
Sep-22-25 08:00AM	Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue (GlobeNewswire) +15.39%
Sep-11-25 08:00AM	Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units (GlobeNewswire) +10.51%
Aug-18-25 12:45PM	Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025 (GlobeNewswire) -5.27%
Aug-12-25 09:50AM	Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy (GlobeNewswire)
Aug-07-25 09:25AM	Cosmos Health secures $300M financing facility to launch Ethereum strategy (TipRanks) -8.70%
Aug-06-25 09:20AM	Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy (GlobeNewswire) +30.98%
Jun-25-25 11:00AM	Cosmos Health enters U.S. market with DolCas Biotech agreement (TipRanks)
Jun-24-25 10:55AM	Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech (GlobeNewswire)
May-15-25 02:30PM	RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire)
09:30AM	Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire)
May-07-25 02:30PM	Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units (GlobeNewswire)
May-06-25 01:40PM	Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq (GlobeNewswire)
Apr-30-25 12:50PM	Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 (GlobeNewswire)
Apr-16-25 12:45PM	Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million (GlobeNewswire)
Apr-09-25 01:40PM	Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L (GlobeNewswire)
Apr-08-25 10:45AM	Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order (GlobeNewswire)
Feb-26-25 11:30AM	Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates (ACCESSWIRE)
Feb-18-25 08:30AM	Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 (ACCESSWIRE)
Feb-11-25 10:15AM	Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market (ACCESSWIRE) -10.28%
Feb-10-25 01:30PM	Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market (ACCESSWIRE)
09:45AM	Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations (ACCESSWIRE)
Feb-07-25 10:00AM	Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility (ACCESSWIRE)
Feb-06-25 03:50PM	Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Chairman & CEOMr. Grigorios Siokas

Chief Financial OfficerMr. Georgios Terzis

Chief Operating OfficerMr. Nikolaos Bardakis

Secretary & Independent DirectorMr. Demetrios G. Demetriades

Head of OncologyProf. Dimitrios Trafalis

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Terzis Georgios	Chief Financial Officer	Jun 16 '26	Buy	0.25	168,135	42,000	2,235,398	Jun 17 09:15 AM
Siokas Grigorios	Chief Executive Officer	Jun 11 '26	Buy	0.21	218,447	45,000	13,481,808	Jun 12 01:22 PM
Siokas Grigorios	Chief Executive Officer	Jun 10 '26	Buy	0.23	701,447	160,000	13,263,361	Jun 12 06:20 AM
Siokas Grigorios	Chief Executive Officer	Feb 12 '26	Buy	0.37	388,532	145,000	8,861,914	Feb 13 10:05 AM
Siokas Grigorios	Chief Executive Officer	Feb 11 '26	Buy	0.41	291,262	120,000	8,473,382	Feb 12 02:20 PM
Siokas Grigorios	Chief Executive Officer	Jan 23 '26	Buy	0.50	90,325	45,000	8,182,120	Jan 26 11:48 AM
Siokas Grigorios	Chief Executive Officer	Jan 20 '26	Buy	0.50	353,321	175,000	8,091,795	Jan 21 10:11 AM
Siokas Grigorios	Chief Executive Officer	Jan 14 '26	Buy	0.45	493,495	220,000	7,738,474	Jan 15 09:40 AM
Siokas Grigorios	Chief Executive Officer	Jan 12 '26	Buy	0.50	113,185	57,000	7,244,979	Jan 13 10:00 AM
Siokas Grigorios	Chief Executive Officer	Jan 08 '26	Buy	0.52	156,190	81,000	7,131,794	Jan 09 11:43 AM
Siokas Grigorios	Chief Executive Officer	Jan 07 '26	Buy	0.52	124,880	65,000	6,975,604	Jan 08 10:41 AM
Siokas Grigorios	Chief Executive Officer	Jan 06 '26	Buy	0.54	133,953	72,000	6,850,724	Jan 07 01:01 PM
Siokas Grigorios	Chief Executive Officer	Dec 19 '25	Buy	0.49	88,314	43,000	6,716,771	Dec 22 10:45 AM
Siokas Grigorios	Chief Executive Officer	Dec 15 '25	Buy	0.42	168,472	70,000	6,628,457	Dec 16 12:17 PM
Siokas Grigorios	Chief Executive Officer	Nov 28 '25	Buy	0.64	76,360	49,000	6,459,985	Dec 01 12:02 PM
Siokas Grigorios	Chief Executive Officer	Nov 25 '25	Buy	0.63	55,732	35,000	6,383,625	Nov 26 12:52 PM
Siokas Grigorios	Chief Executive Officer	Nov 21 '25	Buy	0.68	56,080	38,000	6,327,893	Nov 24 02:47 PM
Siokas Grigorios	Chief Executive Officer	Nov 20 '25	Buy	0.62	51,315	32,000	6,271,813	Nov 21 10:07 AM
Siokas Grigorios	Chief Executive Officer	Nov 19 '25	Buy	0.65	61,614	40,000	6,220,498	Nov 20 11:06 AM

Peers: NUS COTY ELF GIS KHC EPC SPB EL MDLZ MNST

| Held by: VTI IWM VB VBR VDC VXF IWN CALF FNDA FBCG

Index	RUT
Market Cap	1.36B
Enterprise Value	3.10B
Income	239.80M
Sales	5.13B
Book/sh	-4.27
Cash/sh	4.38
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Feb 28, 2014
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	8500
IPO	Dec 16, 2004

P/E	5.78
Forward P/E	4.19
PEG	0.21
P/S	0.27
P/B	-
P/C	3.00
P/FCF	3.65
EV/EBITDA	5.27
EV/Sales	0.60
Quick Ratio	0.74
Current Ratio	1.23
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	2.28
EPS next Y	3.14
EPS next Q	0.62
EPS this Y	25.14%
EPS next Y	18.19%
EPS next 5Y	20.24%
EPS past 3/5Y	-11.96% -4.47%
Sales past 3/5Y	-1.08% -1.89%
EPS Y/Y TTM	-16.34%
Sales Y/Y TTM	3.69%
EPS Q/Q	15.77%
Sales Q/Q	7.82%
Earnings	May 06 AMC
EPS/Sales Surpr.	5.44% 1.09%

Insider Own	2.88%
Insider Trans	-5.99%
Inst Own	102.14%
Inst Trans	-12.15%
ROA	8.63%
ROE	-
ROIC	14.14%
Gross Margin	75.25%
Oper. Margin	9.11%
Profit Margin	4.67%
SMA20	5.35%
SMA50	1.90%
SMA200	-1.57%
Trades

Shs Outstand	103.40M
Shs Float	100.69M
Short Float	8.55%
Short Ratio	5.66
Short Interest	8.61M
52W High	20.40 -35.54%
52W Low	7.56 73.94%
Volatility	4.43% 4.71%
ATR (14)	0.57
RSI (14)	56.45
Beta	0.87
Rel Volume	0.85
Avg Volume	1.52M
Volume	1,299,440

Perf Week	0.31%
Perf Month	16.37%
Perf Quarter	-13.32%
Perf Half Y	-7.65%
Perf YTD	2.02%
Perf Year	26.81%
Perf 3Y	6.91%
Perf 5Y	-75.15%
Perf 10Y	-56.91%
Recom	1.75
Target Price	18.33
Prev Close	12.90
Price	13.15
Change	1.94%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-26	Initiated	Maxim Group	Buy	$20
Nov-26-25	Upgrade	Argus	Hold → Buy
Mar-21-25	Upgrade	DA Davidson	Neutral → Buy	$7.50 → $14
Aug-01-24	Reiterated	B. Riley Securities	Buy	$16 → $17
Sep-14-23	Initiated	DA Davidson	Neutral	$13.50
Jun-07-23	Initiated	Mizuho	Neutral	$13
Feb-03-23	Initiated	BofA Securities	Underperform	$14
Jul-12-22	Upgrade	Jefferies	Hold → Buy	$26
May-17-22	Downgrade	Argus	Buy → Hold
May-04-22	Downgrade	Jefferies	Buy → Hold	$60 → $26
Jun-29-21	Initiated	B. Riley Securities	Buy	$70
Aug-07-20	Upgrade	CFRA	Sell → Buy
Dec-04-19	Resumed	Citigroup	Buy	$55
Aug-02-19	Reiterated	Pivotal Research Group	Buy	$75 → $65
Apr-10-19	Downgrade	Argus	Buy → Hold
Jan-04-19	Resumed	Argus	Buy	$72
Oct-31-18	Reiterated	Pivotal Research Group	Buy	$75 → $62
Oct-11-18	Initiated	Jefferies	Buy
Mar-06-18	Upgrade	Citigroup	Neutral → Buy
Feb-22-18	Reiterated	Citigroup	Neutral	$73 → $85

Show Previous Ratings

Jul-01-26 07:05AM	Herbalife to Announce Second Quarter 2026 Results on August 5 (Business Wire)
Jun-03-26 04:30PM	Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists (Business Wire) -5.00%
Jun-02-26 07:05AM	Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11 (Business Wire)
May-15-26 08:00AM	Roman DBDR Acquisition Corp. II Appoints Hunter Gary to Board of Directors and Al Basseri as Chief Technology Officer, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions (Business Wire)
May-08-26 07:00AM	Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with "Fuel Like Ronaldo" Campaign (Business Wire)
08:30AM	Loading…
May-07-26 08:30AM	Herbalife Nutrition Ltd. Q1 2026 Earnings Call Summary (Moby) -11.86%
May-06-26 04:10PM	Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints (Business Wire)
Apr-30-26 04:18PM	Pershing Square Shares Rebound After Ackman Bought Stock (Bloomberg)
Apr-29-26 04:15PM	Herbalife Completes $1.45 Billion Senior Secured Refinancing (Business Wire)
Apr-15-26 07:02PM	Herbalife Announces Pricing of $800 Million Aggregate Principal Amount of Senior Secured Notes Offering (Business Wire)
Apr-14-26 08:01AM	Herbalife Announces Proposed Offering of $800 Million Aggregate Principal Amount of Senior Secured Notes (Business Wire) +7.34%
08:00AM	Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans (Business Wire)
Apr-10-26 08:11PM	Should Value Investors Buy Herbalife Ltd (HLF) Stock? (Quartz)
Apr-01-26 07:05AM	Herbalife to Announce First Quarter 2026 Results on May 6 (Business Wire)
Mar-26-26 11:10AM	Herbalife Acquires Cristiano Ronaldo-backed Supplement Company Bioniq (WWD)
06:30AM	Loading…
06:30AM	Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq (Business Wire)
Mar-10-26 09:50AM	Herbalife Ltd (HLF) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Mar-09-26 09:40AM	Should Value Investors Buy Herbalife Ltd (HLF) Stock? (Zacks) +7.95%
Mar-06-26 08:32AM	Best Health & Fitness Stocks to Buy Now for Strong Growth (Zacks)
Mar-05-26 09:00AM	Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments (PR Newswire) -6.04%
Mar-03-26 11:08PM	Herbalife (HLF): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -7.80%
Feb-25-26 12:38AM	5 Insightful Analyst Questions From Herbalife's Q4 Earnings Call (StockStory)
Feb-24-26 09:40AM	Herbalife Ltd (HLF) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Feb-23-26 07:05AM	Herbalife Plans to Refinance Senior Secured Debt (Business Wire)
Feb-21-26 10:54AM	Bill Ackman Bought Only 1 New Stock. Heres Why the Billionaire is Bullish on Meta (24/7 Wall St.)
Feb-20-26 09:40AM	Are Investors Undervaluing Herbalife Ltd (HLF) Right Now? (Zacks)
08:55AM	NYSE Content Update: Starfighters Space Celebrates NYSE American Listing (PR Newswire)
07:19AM	Best Value Stocks to Buy for February 20th (Zacks)
07:18AM	New Strong Buy Stocks for February 20th (Zacks)
04:33AM	Herbalife (HLF) Climbs to 3-Year High on Net Sales Beat (Insider Monkey)
11:42AM	Loading…
Feb-19-26 11:42AM	Cristiano Ronaldo's Herbalife deal, Klarna set for worst trading day (Yahoo Finance Video) +18.32%
10:51AM	HLF Q4 Deep Dive: Product Innovation, Distributor Growth, and Digital Personalization Drive Outlook (StockStory)
08:30AM	Herbalife Nutrition Ltd. Q4 2025 Earnings Call Summary (Moby)
03:40AM	Cristiano Ronaldo Sends Herbalife Shares Up 14% After Hours (Benzinga)
12:02AM	Herbalife Ltd (HLF) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Debt ... (GuruFocus.com)
Feb-18-26 11:06PM	Herbalife Q4 Earnings Call Highlights (MarketBeat)
05:45PM	Herbalife Ltd (HLF) Misses Q4 Earnings and Revenue Estimates (Zacks)
04:50PM	Warren Buffett Disciple Seth Klarman Differs With Mentor On This Magnificent Seven Stock: One Is Buying, One Is Selling (Benzinga)
04:41PM	Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7% (StockStory)
04:12PM	Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance (Business Wire)
04:10PM	Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col Technology, Acquires 10% Equity Stake (Business Wire)
Feb-16-26 10:02PM	Herbalife (HLF) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jan-29-26 11:32PM	1 Russell 2000 Stock Worth Investigating and 2 That Underwhelm (StockStory)
Jan-23-26 12:10PM	Will Herbalife Ltd (HLF) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-16-26 10:26AM	Here's What the Wall Street Thinks About ?Herbalife Ltd. (HLF) (Insider Monkey)
Jan-14-26 11:36PM	3 Overrated Stocks Walking a Fine Line (StockStory)
Jan-07-26 08:26AM	Herbalife initiated with a Buy at Maxim (TipRanks)
08:00AM	Stocks making big moves yesterday: Herbalife, Vertex Pharmaceuticals, Micron, Amkor, and Palantir Technologies (StockStory)
Jan-06-26 03:05PM	Why Is Herbalife (HLF) Stock Soaring Today (StockStory) +9.22%
Jan-05-26 07:05AM	Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18 (Business Wire)
Dec-17-25 11:35PM	3 Cash-Producing Stocks with Questionable Fundamentals (StockStory)
Dec-11-25 11:40AM	Why Herbalife (HLF) Stock Is Up Today (StockStory)
Dec-08-25 11:02PM	Herbalife (HLF): Buy, Sell, or Hold Post Q3 Earnings? (StockStory) +6.35%
11:50AM	Why Herbalife (HLF) Stock Is Down Today (StockStory)
Dec-04-25 10:35PM	Q3 Earnings Highs And Lows: Herbalife (NYSE:HLF) Vs The Rest Of The Personal Care Stocks (StockStory)
Nov-26-25 12:35PM	Why Herbalife (HLF) Stock Is Trading Up Today (StockStory) +12.76%
09:43AM	Autodesk upgraded, Nio downgraded: Wall Street's top analyst calls (The Fly)
Nov-25-25 07:05AM	Herbalife CFO Fireside Chat Webcast from Furey Research Partners Hidden Gems Conference Available (Business Wire)
Nov-23-25 11:31PM	1 Russell 2000 Stock Worth Investigating and 2 We Brush Off (StockStory)
Nov-19-25 11:35PM	1 Value Stock on Our Watchlist and 2 We Brush Off (StockStory)
07:05AM	Herbalife CEO and CFO to Participate in BofA Securities Leveraged Finance Conference on December 2 (Business Wire)
Nov-09-25 11:35PM	3 Consumer Stocks with Warning Signs (StockStory)
Nov-06-25 11:37AM	Why Are Herbalife (HLF) Shares Soaring Today (StockStory) +11.65%
09:16AM	HLF Q3 Deep Dive: Personalization Initiatives and Distributor Momentum Support Modest Growth (StockStory)
12:14AM	Herbalife Ltd (HLF) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Debt ... (GuruFocus.com)
Nov-05-25 04:50PM	Herbalife (NYSE:HLF) Beats Q3 Sales Expectations, Stock Soars (StockStory)
04:10PM	Herbalife Delivers Q3 Net Sales Increase Above Guidance Midpoint, North America Returns to Growth; Q3 Adjusted EBITDA1 Exceeds Guidance; Tightens Full-Year Guidance Ranges (Business Wire)
03:59PM	Legendary Investor Carl Icahn Is Betting Big on Monro Stock. Should You Buy MNRO Here? (Barchart)
Nov-04-25 08:12AM	What to Expect from Herbalife Ltd (HLF) Q3 2025 Earnings (GuruFocus.com)
Nov-03-25 10:09PM	Herbalife Earnings: What To Look For From HLF (StockStory)
Oct-30-25 03:20PM	Herbalife Receives Direct Selling Association's 2025 Vision for Tomorrow Award for its Casa Herbalife Program (Business Wire)
Oct-27-25 04:05AM	Herbalife Advances Global Nutrition Innovation with New State-of-the-Art Center of Excellence (Business Wire)
Oct-13-25 02:39PM	Herbalife Named to Forbes' Inaugural List of America's Best Brands for Value (Business Wire)
Oct-08-25 12:31AM	3 Stocks Under $10 We're Skeptical Of (StockStory)
Oct-06-25 12:32AM	1 Unpopular Stock That Should Get More Attention and 2 We Turn Down (StockStory)
Oct-02-25 12:03AM	3 Reasons to Sell HLF and 1 Stock to Buy Instead (StockStory)
Oct-01-25 07:05AM	Herbalife to Announce Third Quarter 2025 Results on November 5 (Business Wire)
Sep-25-25 12:33AM	3 Low-Volatility Stocks We're Skeptical Of (StockStory)
Aug-31-25 11:34PM	Personal Care Stocks Q2 Results: Benchmarking Herbalife (NYSE:HLF) (StockStory)
Aug-29-25 01:46PM	Herbalife (HLF) Shares Skyrocket, What You Need To Know (StockStory) +6.65%
Aug-25-25 12:39AM	1 Small-Cap Stock Worth Your Attention and 2 Facing Challenges (StockStory)
Aug-19-25 03:37PM	Herbalife (HLF) Shares Skyrocket, What You Need To Know (StockStory)
07:05AM	Herbalife CEO and CFO to Participate in Barclays Global Consumer Staples Conference on September 2 (Business Wire)
Aug-18-25 12:31AM	3 Russell 2000 Stocks We Keep Off Our Radar (StockStory)
Aug-13-25 01:36AM	Herbalife's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory) +6.44%
12:30AM	Herbalife India Launches Independence Day Week Episode of Its Flagship Podcast Featuring Smriti Mandhana (PR Newswire)
Aug-12-25 11:41PM	Herbalife Ltd. (HLF) Reports Q2 2025 Results; Mizuho Lifts PT to $9 (Insider Monkey)
03:13AM	HLF Q2 Deep Dive: Product Innovation and Digital Transformation Take Center Stage (StockStory)
Aug-08-25 04:29AM	Herbalife India Recognised as 'Leader of the Year - Consumer Health' at the 12th IAA Leadership Awards (PR Newswire)
Aug-07-25 03:00PM	Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside? (Zacks) -6.81%
Aug-06-25 06:05PM	Herbalife (NYSE:HLF) Misses Q2 Revenue Estimates (StockStory)
04:10PM	Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA1 Full-Year Guidance (Business Wire)
Aug-05-25 11:00PM	4 in 5 APAC consumers take health supplements but half lack confidence in making good supplement choices - Herbalife survey (PR Newswire)
09:59AM	Herbalife Ltd (HLF) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-04-25 11:03PM	Herbalife (HLF) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-23-25 11:31PM	Reflecting On Personal Care Stocks' Q1 Earnings: Herbalife (NYSE:HLF) (StockStory) +12.81% -8.77%
03:00PM	CVS Q2 Estimates Dip: Is the Stock Still a Buy Ahead of Q2 Earnings? (Zacks)
Jul-16-25 09:52AM	Plant-based Supplements Market - Global Forecast to 2030 \| Rising Demand for Plant-Based Supplements Spurs Market Growth through Preventive Health Strategies (GlobeNewswire)
Jul-15-25 12:04AM	3 Reasons to Avoid HLF and 1 Stock to Buy Instead (StockStory)
Jul-07-25 08:19AM	Herbalife Launches MultiBurn: A Science-Backed Weight Loss Supplement Supporting Metabolic Health (Business Wire)

Herbalife Ltd. is a holding company, which engages in the provision of health and wellness products. It operates through the following geographical segments: North America, Latin America, EMEA, Asia Pacific, and China. The company was founded by Mark Reynolds Hughes in February 1980 and is headquartered in Los Angeles, CA.

Executive ChairmanMr. Michael O. Johnson

Chief Executive OfficerMr. Stephan Paulo Gratziani

PresidentMr. Robert C. Levy

Chief Financial OfficerMr. John G. DeSimone

Chief Legal Officer & Corporate SecretaryMr. Henry C. Wang

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
L'Helias Sophie	Director	Jun 04 '26	Buy	11.31	1,200	13,572	79,882	Jun 04 06:33 PM
Hicks Troy	Chief Operating Officer	May 18 '26	Option Exercise	9.31	83,270	775,526	77,770	May 20 08:50 PM
Hicks Troy	Chief Operating Officer	May 18 '26	Sale	12.93	38,377	496,311	9,062	May 20 08:50 PM
Hicks Troy	Chief Operating Officer	May 19 '26	Sale	12.32	10,000	123,245	9,706	May 20 08:50 PM
Hicks Troy	Officer	May 19 '26	Proposed Sale	12.32	10,000	123,245		May 19 04:55 PM
Hicks Troy	Officer	May 18 '26	Proposed Sale	12.93	38,377	496,309		May 18 04:28 PM
Lamberti Frank	Chief Commercial Officer	May 12 '26	Sale	13.50	134,982	1,822,257	36,624	May 12 09:59 PM
Lamberti Frank	Chief Commercial Officer	May 11 '26	Sale	13.86	7,937	110,002	171,606	May 12 09:59 PM
Lamberti Frank	Officer	May 12 '26	Proposed Sale	13.50	134,982	1,822,211		May 12 04:50 PM
Lamberti Frank	Officer	May 11 '26	Proposed Sale	13.86	7,937	110,002		May 11 04:12 PM
L'Helias Sophie	Director	Dec 01 '25	Buy	12.70	800	10,160	66,803	Dec 01 09:00 PM
L'Helias Sophie	Director	Nov 26 '25	Buy	13.22	400	5,288	66,003	Dec 01 09:00 PM
Cloud Lynda	Director	Nov 18 '25	Buy	8.97	17,000	152,490	38,857	Nov 20 08:41 PM

NUS Nu Skin Enterprises Inc daily Stock Chart

Peers: USNA EPC COTY EL ELF IPAR NATR HLF CL MED

| Held by: AVUV VTI IWM FNDA VDC VXF IWN VTWO DES SCHA

Index	RUT
Market Cap	253.92M
Enterprise Value	331.12M
Income	54.52M
Sales	1.44B
Book/sh	16.34
Cash/sh	4.13
Dividend Est.	-
Dividend TTM	0.24 (4.59%)
Dividend Ex-Date	May 29, 2026
Dividend Gr. 3/5Y	-46.19% -30.69%
Payout	7.54%
Employees	8600
IPO	Nov 22, 1996

P/E	4.78
Forward P/E	3.96
PEG	-
P/S	0.18
P/B	0.32
P/C	1.27
P/FCF	6.11
EV/EBITDA	2.51
EV/Sales	0.23
Quick Ratio	1.34
Current Ratio	2.03
Debt/Eq	0.35
LT Debt/Eq	0.32
Option/Short	Yes / Yes

EPS (ttm)	1.09
EPS next Y	1.32
EPS next Q	0.20
EPS this Y	-21.26%
EPS next Y	32.00%
EPS next 5Y	-
EPS past 3/5Y	15.37% -2.56%
Sales past 3/5Y	-12.61% -10.47%
EPS Y/Y TTM	242.44%
Sales Y/Y TTM	-14.17%
EPS Q/Q	-98.26%
Sales Q/Q	-12.04%
Earnings	May 07 AMC
EPS/Sales Surpr.	-6.67% -2.76%

Insider Own	2.95%
Insider Trans	-1.18%
Inst Own	75.29%
Inst Trans	-2.00%
ROA	3.94%
ROE	7.04%
ROIC	5.18%
Gross Margin	69.31%
Oper. Margin	5.66%
Profit Margin	3.78%
SMA20	1.49%
SMA50	-9.45%
SMA200	-39.17%
Trades

Shs Outstand	48.60M
Shs Float	47.12M
Short Float	8.06%
Short Ratio	5.64
Short Interest	3.80M
52W High	14.62 -64.23%
52W Low	4.89 6.95%
Volatility	3.01% 4.39%
ATR (14)	0.23
RSI (14)	45.72
Beta	0.96
Rel Volume	1.07
Avg Volume	673.58K
Volume	724,069

Perf Week	4.39%
Perf Month	-3.86%
Perf Quarter	-31.45%
Perf Half Y	-48.12%
Perf YTD	-45.63%
Perf Year	-43.94%
Perf 3Y	-82.52%
Perf 5Y	-90.73%
Perf 10Y	-89.04%
Recom	3.00
Target Price	7.50
Prev Close	5.13
Price	5.23
Change	1.95%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-31-23	Downgrade	Jefferies	Buy → Hold	$43 → $39
Feb-12-21	Downgrade	DA Davidson	Buy → Neutral
Oct-02-20	Upgrade	BofA Securities	Underperform → Neutral	$54 → $58
Jul-02-20	Upgrade	Jefferies	Hold → Buy	$42 → $50
Jul-02-20	Upgrade	DA Davidson	Neutral → Buy
Mar-09-20	Downgrade	Deutsche Bank	Buy → Hold	$40 → $28
Dec-05-19	Resumed	Citigroup	Neutral
Nov-06-19	Downgrade	Citigroup	Buy → Neutral
Oct-30-19	Upgrade	Stifel	Sell → Hold	$38.50 → $45
Jul-17-19	Downgrade	Jefferies	Buy → Hold	$40
Jul-17-19	Downgrade	DA Davidson	Buy → Neutral	$38
Jun-19-19	Reiterated	BofA/Merrill	Underperform	$57 → $52
May-01-19	Upgrade	Deutsche Bank	Hold → Buy
May-01-19	Reiterated	BofA/Merrill	Underperform	$52 → $57
Apr-12-19	Reiterated	BofA/Merrill	Underperform	$65 → $52
Mar-25-19	Downgrade	Stifel	Hold → Sell	$63 → $43
Dec-06-18	Reiterated	BofA/Merrill	Underperform	$75 → $65
Oct-10-18	Initiated	DA Davidson	Buy	$92
Aug-03-18	Upgrade	Stifel	Sell → Hold	$57 → $70
Jun-14-18	Initiated	Jefferies	Buy	$98

Show Previous Ratings

May-15-26 07:00AM	Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition (Business Wire)
May-08-26 01:34PM	Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26 (Newsfile)
08:30AM	Nu Skin Enterprises, Inc. Q1 2026 Earnings Call Summary (Moby)
May-07-26 05:54PM	Nu Skin: Q1 Earnings Snapshot (Associated Press)
04:06PM	Nu Skin Enterprises Reports First Quarter Results (Business Wire)
04:05PM	Loading…
04:05PM	Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
Apr-13-26 04:05PM	Nu Skin Enterprises to Announce First Quarter 2026 Financial Results (Business Wire)
Apr-02-26 04:25PM	Nu Skin Launches Prysm iO: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness (Business Wire)
Mar-20-26 04:05PM	Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer (Business Wire)
Mar-09-26 04:05PM	Nu Skin Appoints Chayce Clark as COO (Business Wire)
Feb-13-26 10:02AM	Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y (Zacks) -18.12%
09:43AM	Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4 (Newsfile)
08:30AM	Nu Skin Enterprises, Inc. Q4 2025 Earnings Call Summary (Moby)
05:47AM	Nu Skin Stock Sinks After Weak Quarter, Soft Outlook (Benzinga)
01:09AM	Nu Skin Enterprises Q4 Earnings Call Highlights (MarketBeat)
12:03AM	Loading…
12:03AM	Nu Skin Enterprises Inc (NUS) Q4 2025 Earnings Call Highlights: Strong Earnings Growth and ... (GuruFocus.com)
Feb-12-26 05:55PM	Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Miss Estimates (Zacks)
04:53PM	Nu Skin: Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance (Business Wire)
04:05PM	Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
Feb-11-26 10:46AM	Nu Skin Gears Up to Report Q4 Earnings: What's in the Offing? (Zacks)
Feb-06-26 01:56PM	Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness (Business Wire)
Feb-05-26 07:10AM	Estee Lauder (EL) Q2 Earnings and Revenues Top Estimates (Zacks)
Jan-14-26 04:41PM	Stonegate Attends ICR 2026, Highlighted by Fireside Chat with Nu Skin (NUS) (Newsfile)
04:05PM	Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Jan-09-26 07:00AM	Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference (Business Wire)
Dec-30-25 06:01PM	Nu Skin Releases 2024 Social Impact and Sustainability Report (Business Wire)
10:37AM	Is e.l.f. Beauty's Gross Margin Poised to Rebound in 2H26? (Zacks)
Dec-23-25 11:17AM	Is ELF's Pricing Strategy Offsetting Tariff-Driven Costs Through 2026? (Zacks)
Dec-18-25 10:01AM	Nu Skin Unveils Prysm iO: An Evolution in Intelligent Nutritional Wellness (Business Wire)
08:40AM	Loading…
08:40AM	3 Beauty & Cosmetic Stocks Positioned Well for Sustainable Growth (Zacks)
Dec-17-25 11:13AM	Can Brand-Led Innovation Sustain ELF's Growth Momentum in FY26? (Zacks)
Dec-12-25 08:41AM	e.l.f. Beauty Tumbles 38% in 2025: How to Play the Stock for 2026? (Zacks)
Dec-09-25 12:28PM	Will Rhode Acquisition Become ELF's Key Growth Catalyst in FY26? (Zacks)
Nov-25-25 08:06AM	3 Beauty & Cosmetic Stocks Set to Ride on the Next Wave of Growth (Zacks)
Nov-07-25 08:45AM	Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q3 (Newsfile) -15.79%
12:07AM	Nu Skin Enterprises Inc (NUS) Q3 2025 Earnings Call Highlights: Strong Growth in Latin America ... (GuruFocus.com)
Nov-06-25 04:29PM	Nu Skin: Q3 Earnings Snapshot (Associated Press Finance)
04:06PM	Nu Skin Enterprises Reports Third Quarter Earnings (Business Wire)
04:05PM	Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
Nov-05-25 05:20PM	e.l.f. Beauty (ELF) Beats Q2 Earnings Estimates (Zacks)
07:17AM	Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock? (Zacks)
Oct-16-25 04:05PM	Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results (Business Wire)
Sep-30-25 04:05PM	Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Second Consecutive Year (Business Wire)
Sep-23-25 06:12AM	Strength Seen in Nu Skin (NUS): Can Its 6.2% Jump Turn into More Strength? (Zacks)
Sep-19-25 11:30AM	Coty (COTY) Up 12.1% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-08-25 04:59PM	Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NUS) (Newsfile) +8.90% +18.48%
03:39AM	Nu Skin Enterprises Inc (NUS) Q2 2025 Earnings Call Highlights: Strong Latin American Growth ... (GuruFocus.com)
Aug-07-25 05:36PM	Nu Skin: Q2 Earnings Snapshot (Associated Press Finance)
04:06PM	Nu Skin Enterprises Reports Second Quarter Revenue at High End of Guidance and Earnings Per Share Above Guidance (Business Wire)
04:05PM	Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
Jul-10-25 04:05PM	Nu Skin Enterprises to Announce Second Quarter 2025 Financial Results (Business Wire)
Jun-25-25 04:05PM	Nu Skin Expands and Repackages ageLOC Tru Face Line, Setting a New Standard for Sustainable Skincare (Business Wire)
Jun-10-25 12:00AM	3 Reasons to Avoid NUS and 1 Stock to Buy Instead (StockStory)
Jun-02-25 12:19PM	Nu Skin Enterprises Appoints James Winett to Board of Directors (Business Wire)
May-09-25 03:45AM	Nu Skin Enterprises Inc (NUS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com) +11.04%
May-08-25 04:39PM	Nu Skin: Q1 Earnings Snapshot (Associated Press Finance) +7.13%
04:06PM	Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance (Business Wire)
04:05PM	Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
Apr-24-25 09:01AM	2 Small-Cap Stocks on Our Watchlist and 1 to Brush Off (StockStory)
Apr-18-25 03:22PM	Is Nu Skin Enterprises, Inc. (NUS) the Best Cosmetics Stock to Buy for 2025? (Insider Monkey)
Apr-17-25 10:49AM	Top Beauty and Cosmetics Stocks to Boost Your Portfolio (Zacks)
Apr-15-25 05:08AM	Winners And Losers Of Q4: Nu Skin (NYSE:NUS) Vs The Rest Of The Personal Care Stocks (StockStory)
Apr-02-25 04:15PM	Nu Skin Enterprises to Announce First Quarter 2025 Financial Results (Business Wire)
10:14AM	KMB Stock Gains 10% in 3 Months: Should You Buy Now or Hold Steady? (Zacks)
05:11AM	3 Reasons NUS is Risky and 1 Stock to Buy Instead (StockStory)
Mar-27-25 10:03AM	Church & Dwight Stock Trading at a Premium: Time to Hold or Fold? (Zacks) +8.37%
Mar-26-25 04:52PM	Why Nu Skin Enterprises (NUS) Is Surging in 2025? (InsiderMonkey)
Mar-25-25 01:10PM	Is Nu Skin Enterprises, Inc. (NUS) the Best Household Stock to Buy According to Hedge Funds? (InsiderMonkey) -6.68%
Mar-24-25 01:10PM	COTY Exits SKKN by Kim Partnership With Stake Sale to SKIMS (Zacks)
Mar-19-25 11:08AM	KMB Trades Above 50 & 200-Day SMA: How Should Investors Play? (Zacks)
09:40AM	Are Consumer Staples Stocks Lagging Heineken (HEINY) This Year? (Zacks)
05:00AM	Zacks.com featured highlights OppFi, Nu Skin, BJ's Restaurants, MRC Global and KT (Zacks)
Mar-07-25 08:01AM	3 Value Stocks Walking a Fine Line (StockStory)
Feb-28-25 08:01AM	3 Small-Cap Stocks in the Doghouse (StockStory)
Feb-25-25 09:40AM	Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year? (Zacks) +5.62%
Feb-18-25 08:05AM	Earnings To Watch: Herbalife (HLF) Reports Q4 Results Tomorrow (StockStory)
Feb-14-25 07:43AM	Q4 2024 NU Skin Enterprises Inc Earnings Call (Thomson Reuters StreetEvents) +17.76%
02:22AM	Nu Skin Enterprises Inc (NUS) Q4 2024 Earnings Call Highlights: Strong Revenue Performance ... (GuruFocus.com)
Feb-13-25 05:50PM	Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Top Estimates (Zacks)
05:24PM	Nu Skin (NYSE:NUS) Surprises With Q4 Sales, Stock Jumps 22.3% (StockStory)
04:50PM	Nu Skin: Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance (Business Wire)
04:05PM	Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
Feb-12-25 08:02AM	Nu Skin Earnings: What To Look For From NUS (StockStory)
Feb-09-25 02:02PM	Nu Skin Enterprises, Inc. (NUS) Among the Best Hair Care Stocks to Buy (Insider Monkey)
Feb-06-25 10:01AM	Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-13-25 12:56PM	Nu Skin (NUS) Shares Skyrocket, What You Need To Know (StockStory) +9.81%
07:00AM	Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance (Business Wire)
Jan-06-25 08:44AM	Nu Skin Sells Its Mavely Amidst Industry Competition (GuruFocus.com) -7.57%
Jan-04-25 06:29AM	Nu Skin Sells Mavely Platform to Later for $250M (TipRanks)
Jan-03-25 10:29AM	Nu Skin (NUS) Shares Skyrocket, What You Need To Know (StockStory) +14.79%
09:38AM	Nu Skin (NUS) Up 17% at Pre-Market Trade After Raising $250M Fresh Funds (Insider Monkey)
09:38AM	Nu Skin Enterprises jumps on a deal to sell its Mavely marketing tech platform (Investing.com)
08:22AM	Why Is Nu Skin Enterprises Stock Jumping Today? (Benzinga)
06:00AM	Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million (Business Wire)
06:00AM	Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social (PR Newswire)
Dec-03-24 03:00AM	Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3 (StockStory)
Nov-29-24 04:35AM	Nu Skin (NUS): Buy, Sell, or Hold Post Q3 Earnings? (StockStory) -5.07%
Nov-27-24 03:09AM	Personal Care Stocks Q3 Teardown: Olaplex (NASDAQ:OLPX) Vs The Rest (StockStory)

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia and Pacific, Japan, Hong Kong and Taiwan, and Europe and Africa. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Co-Founder & Executive Chairman of the BoardMr. Steven J. Lund J.D.

PresidentMr. Ryan S. Napierski

Executive VPMr. Chayce David Clark

Executive VP & President of Global SalesMr. Justin S. Keisel

FounderMr. Blake M. Roney

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Winett James M	Director	Jun 02 '26	Sale	5.62	7,203	40,481	37,448	Jun 03 05:10 PM
WOODBURY EDWINA D	Director	Jun 01 '26	Sale	5.70	7,203	41,057	62,433	Jun 03 05:07 PM
Winett James M	Director	Jun 02 '26	Proposed Sale	5.62	7,203	40,481		Jun 02 10:38 AM
WOODBURY EDWINA D	Director	Jun 01 '26	Proposed Sale	5.70	7,203	41,057		Jun 01 12:24 PM
Nathanson Laura	Director	May 11 '26	Sale	6.73	2,676	18,009	30,473	May 12 04:58 PM
Nathanson Laura	Director	May 11 '26	Proposed Sale	7.16	2,676	19,160		May 11 02:53 PM
Hatchett Steven Keith	Chief Product Officer	Nov 11 '25	Buy	9.61	5,500	52,855	167,565	Nov 12 04:32 PM
Nathanson Laura	Director	Sep 04 '25	Sale	12.22	6,489	79,296	33,149	Sep 04 05:12 PM
Clark Chayce David	EVP and General Counsel	Sep 03 '25	Sale	11.97	20,000	239,400	233,140	Sep 04 05:10 PM
Nathanson Laura	Director	Sep 04 '25	Proposed Sale	12.00	6,489	77,868		Sep 04 04:14 PM
Clark Chayce David	Officer	Sep 03 '25	Proposed Sale	11.97	20,000	239,434		Sep 03 02:56 PM
CAMPBELL DANIEL W	Director	Aug 29 '25	Sale	12.10	23,391	283,031	53,375	Aug 29 05:19 PM
CAMPBELL DANIEL W	Director	Aug 29 '25	Sale	12.12	9,046	109,638	39,216	Aug 29 05:19 PM
CAMPBELL GIFT TRUST	Director	Aug 29 '25	Proposed Sale	12.10	23,391	283,118		Aug 29 04:09 PM
DANIEL WAYNE CAMPBELL & PEGGY	Director	Aug 29 '25	Proposed Sale	12.12	9,046	109,636		Aug 29 04:05 PM

CAH Cardinal Health Inc daily Stock Chart

Peers: COR MCK MDLN HSIC CVS UNH CI ELV HUM AHG

| Held by: VTI VOO VO IVV SPY VTV XLV VOE COWZ VIG

Index	S&P 500
Market Cap	55.23B
Enterprise Value	60.36B
Income	1.55B
Sales	250.74B
Book/sh	-12.05
Cash/sh	16.81
Dividend Est.	2.06 (0.87%)
Dividend TTM	2.05 (0.87%)
Dividend Ex-Date	Jul 01, 2026
Dividend Gr. 3/5Y	1.01% 1.02%
Payout	31.43%
Employees	57700
IPO	Aug 04, 1983

P/E	36.06
Forward P/E	19.58
PEG	1.09
P/S	0.22
P/B	-
P/C	14.03
P/FCF	12.57
EV/EBITDA	14.78
EV/Sales	0.24
Quick Ratio	0.48
Current Ratio	0.91
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	6.54
EPS next Y	12.04
EPS next Q	2.42
EPS this Y	30.77%
EPS next Y	11.75%
EPS next 5Y	17.99%
EPS past 3/5Y	- -
Sales past 3/5Y	7.06% 7.80%
EPS Y/Y TTM	2.04%
Sales Y/Y TTM	12.80%
EPS Q/Q	-19.48%
Sales Q/Q	11.05%
Earnings	Apr 30 BMO
EPS/Sales Surpr.	13.43% -1.87%

Insider Own	0.25%
Insider Trans	-1.53%
Inst Own	90.39%
Inst Trans	-1.41%
ROA	2.92%
ROE	-
ROIC	28.73%
Gross Margin	3.65%
Oper. Margin	1.26%
Profit Margin	0.62%
SMA20	1.66%
SMA50	11.76%
SMA200	16.02%
Trades

Shs Outstand	235.00M
Shs Float	233.62M
Short Float	3.03%
Short Ratio	3.07
Short Interest	7.07M
52W High	243.21 -3.05%
52W Low	137.75 71.18%
Volatility	2.56% 2.45%
ATR (14)	5.58
RSI (14)	64.71
Beta	0.49
Rel Volume	1.23
Avg Volume	2.30M
Volume	2,835,841

Perf Week	-1.31%
Perf Month	10.88%
Perf Quarter	9.27%
Perf Half Y	13.81%
Perf YTD	14.74%
Perf Year	45.40%
Perf 3Y	151.68%
Perf 5Y	312.38%
Perf 10Y	193.36%
Recom	1.48
Target Price	251.27
Prev Close	233.77
Price	235.80
Change	0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-28-26	Initiated	William Blair	Outperform
Jan-09-26	Upgrade	Citigroup	Neutral → Buy
Dec-09-25	Initiated	Barclays	Overweight	$243
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$179
Feb-05-25	Upgrade	Jefferies	Hold → Buy	$140 → $150
Jan-08-25	Upgrade	TD Cowen	Hold → Buy	$130 → $144
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform	$140
Jan-06-25	Upgrade	BofA Securities	Neutral → Buy	$132 → $145
Dec-13-24	Upgrade	Wells Fargo	Underweight → Equal Weight	$101 → $127
Dec-04-24	Resumed	Mizuho	Outperform	$139
Feb-26-24	Initiated	Leerink Partners	Outperform	$125
Feb-09-24	Upgrade	Argus	Hold → Buy
Jan-03-24	Initiated	Barclays	Overweight	$117
Dec-14-23	Initiated	Wells Fargo	Underweight	$96
Jul-10-23	Downgrade	Evercore ISI	Outperform → In-line	$100
Mar-31-23	Initiated	Citigroup	Neutral	$77
Feb-03-23	Upgrade	Robert W. Baird	Neutral → Outperform	$87 → $94
Nov-04-22	Upgrade	BofA Securities	Underperform → Neutral	$64 → $80
Aug-22-22	Resumed	Morgan Stanley	Overweight	$70 → $76
May-26-22	Downgrade	Barclays	Overweight → Equal Weight

Show Previous Ratings

Jul-09-26 09:24AM	McKesson Stock Is Shrinking, and That's The Point for Owners (Trefis)
06:45AM	Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11 (PR Newswire)
Jul-08-26 02:24PM	McKesson Stock Is Shrinking, And That's The Point (Trefis)
May-05-26 04:40PM	Cardinal Health Board of Directors Approves Quarterly Dividend (PR Newswire)
Apr-30-26 04:55PM	Cardinal Health, Inc. Q3 2026 Earnings Call Summary (Moby)
08:07AM	Loading…
08:07AM	Cardinal Health Rises. A Guidance Hike Powers the Stock Past These Weak Points. (Barrons.com)
07:41AM	Cardinal Health Lifts Outlook Again as Revenue Rises (The Wall Street Journal)
06:56AM	Cardinal: Fiscal Q3 Earnings Snapshot (Associated Press)
06:45AM	Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook (PR Newswire)
12:30AM	2 Things Matter Most in Picking Winning Stocks, Says This Market Pro (Barrons.com)
Apr-28-26 11:45AM	Jim Cramer says health care is the 'cold' hedge your AI-heavy portfolio is missing and shares 4 stocks to consider (Moneywise)
10:19AM	Micron initiated, Rambus downgraded: Wall Street's top analyst calls (The Fly)
Apr-20-26 12:12PM	McKesson Stock: A Compounding Engine Facing Its Critical Test (Trefis)
Apr-14-26 07:00AM	Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings (PR Newswire)
Apr-07-26 08:20PM	Is Cardinal Health (CAH) Stock Undervalued Right Now? (Quartz)
07:00AM	Loading…
Apr-01-26 07:00AM	Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies (PR Newswire)
Mar-24-26 06:45AM	Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 (PR Newswire)
Mar-23-26 06:45AM	Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair (PR Newswire)
Mar-13-26 04:41PM	How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro (Investor's Business Daily)
09:55AM	Is Cardinal Health Stock Outperforming the Dow? (Barchart)
Mar-10-26 01:11PM	GEHC Wins FDA 510(k) Approval for View, Enhances Radiology Workflows (Zacks)
10:55AM	Here's Why You Should Retain CONMED Stock in Your Portfolio Now (Zacks)
Mar-09-26 11:53AM	Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment (Zacks)
09:40AM	Is Adlai Nortye Ltd. Sponsored ADR (ANL) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-06-26 07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
11:49AM	Here's Why You Should Add DaVita Stock to Your Portfolio for Now (Zacks)
11:45AM	Why Cardinal Health May Be a Best Buy for the Coming Stagflation (24/7 Wall St.)
11:44AM	BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease (Zacks)
Mar-05-26 12:46PM	BD Gains FDA Clearance for Surgiphor 1000mL Surgical Irrigation System (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
09:30AM	Loading…
09:30AM	Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
07:43AM	EYE Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
Mar-04-26 11:35AM	When Fear Hits the Stock Market, Where Can Investors Find Safety? (Barchart)
08:30AM	Cryoport, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-03-26 10:38PM	Q4 Earnings Roundup: Cardinal Health (NYSE:CAH) And The Rest Of The Healthcare Providers & Services Segment (StockStory)
07:02PM	CryoPort Q4 Earnings Call Highlights (MarketBeat)
09:40AM	Here's Why Cardinal Health (CAH) is a Strong Value Stock (Zacks)
09:15AM	Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue? (Zacks)
Mar-02-26 12:59PM	OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis (Zacks)
09:40AM	Should Value Investors Buy Cardinal Health (CAH) Stock? (Zacks)
09:36AM	Cooper Companies to Post Q1 Earnings: Is a Beat in the Offing? (Zacks)
07:41AM	PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
07:41AM	Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up (Zacks)
Feb-28-26 01:28PM	Cardinal Health, Inc. (CAH): A Bull Case Theory (Insider Monkey)
Feb-27-26 12:45PM	Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down (Zacks)
12:38PM	CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash (Zacks)
12:37PM	GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery (Zacks)
07:42AM	TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market (Zacks)
Feb-26-26 08:04PM	3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR (Zacks)
07:12PM	Analyst Report: McKesson Corporation (Morningstar Research)
11:46AM	GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow (Zacks)
11:22AM	Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises (Zacks)
Feb-25-26 01:55PM	Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand (Zacks)
01:55PM	FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand (Zacks)
12:51PM	Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y (Zacks)
12:49PM	Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y (Zacks)
07:50AM	Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y (Zacks)
07:26AM	TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market (Zacks)
Feb-24-26 12:40PM	BD Launches Urine Complete Cup Kit for Smarter Testing & Accuracy (Zacks)
12:15PM	Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract (Zacks)
08:46AM	HSIC Q4 Earnings & Revenues Beat Estimates, Margins Down (Zacks)
07:45AM	MYGN Stock Up on Q4 Earnings and Revenue Beat, Gross Margin Down (Zacks)
07:00AM	Cardinal Health report highlights cost savings and provider confidence in biosimilars (PR Newswire)
Feb-23-26 03:35PM	Top Stock Picks for Week of February 23, 2026 (Zacks)
12:42PM	ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation (Zacks)
10:11AM	Bull of the Day: Cardinal Health (CAH) (Zacks)
09:32AM	Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Feb-20-26 06:11PM	Wells Fargo Raises Outlook on Cardinal Health (CAH), Cites Broad Business Strength (Insider Monkey)
12:22PM	GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio (Zacks)
11:48AM	AMN Q4 Earnings Meet Estimates, Revenues Beat, Gross Margin Contracts (Zacks)
09:11AM	TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up (Zacks)
04:13AM	Zacks Investment Ideas feature highlights Cardinal Health and Palantir (Zacks)
Feb-19-26 04:44PM	Q4 Earnings: These Buy-Rated Stocks Crushed Expectations (Zacks)
12:08PM	STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years (Zacks)
09:40AM	Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year? (Zacks)
08:33AM	Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down (Zacks)
08:16AM	Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up (Zacks)
08:09AM	PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
Feb-18-26 08:55AM	CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
04:08AM	Zacks.com featured highlights include Boot Barn, Brinker International, Tapestry and Cardinal Health (Zacks)
Feb-17-26 10:51AM	BOOT & 3 Other Stocks With Strong Interest Coverage to Buy Now (Zacks)
10:07AM	Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market (Zacks)
09:42AM	MDT Stock Up on Q3 Earnings and Revenue Beat, Margins Down (Zacks)
09:30AM	Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest? (Zacks)
Feb-16-26 10:05AM	Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down (Zacks)
12:01AM	Top Picks 2026- Cardinal Health Inc. CAH (MoneyShow)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks)
10:00AM	Best Momentum Stock to Buy for February 13th (Zacks)
09:40AM	Are Investors Undervaluing Cardinal Health (CAH) Right Now? (Zacks)
02:11AM	Former Karaoke Company Drags Logistics Into the AI Scare Trade (Bloomberg)
Feb-12-26 04:45PM	Cardinal Health Board of Directors Approves Quarterly Dividend (PR Newswire)
11:03AM	BAX Stock Falls Following Q4 Earnings Miss, Margins Contract (Zacks)
10:54AM	INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands (Zacks)
10:41AM	AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline (Zacks)
09:40AM	Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term (Zacks)
09:25AM	QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down (Zacks)
09:23AM	Envista Stock Rises Post Q4 Earnings & Revenue Beat, Gross Margin Down (Zacks)
09:18AM	PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Up (Zacks)
12:37AM	The 5 Most Interesting Analyst Questions From Cardinal Health's Q4 Earnings Call (StockStory)
Feb-11-26 01:34PM	BD Merges Biosciences & Diagnostics Business With Waters (Zacks)

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

CEO & DirectorMr. Jason M. Hollar

Chief Financial OfficerMr. Aaron E. Alt J.D.

Chief Legal & Compliance OfficerMs. Jessica L. Mayer

Chief Executive Officer of GMPD segmentMr. Stephen M. Mason

Chief Executive Officer of Pharmaceutical & Specialty Solutions SegmentMs. Deborah L. Weitzman

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gregory Kenny	Former Director	Jun 08 '26	Proposed Sale	203.84	43,542	8,875,761		Jun 08 04:01 PM
Greene Michelle D.	Chief Information Officer	Feb 27 '26	Sale	228.47	2,746	627,387	12,230	Mar 03 04:11 PM
Michelle Greene	officer	Feb 27 '26	Proposed Sale	228.47	2,746	627,387		Feb 27 04:36 PM
Alt Aaron E	Chief Financial Officer	Feb 18 '26	Sale	225.50	2,328	524,964	26,408	Feb 18 04:25 PM
Aaron Alt	Officer	Feb 18 '26	Proposed Sale	225.50	2,328	524,964		Feb 18 04:16 PM
Hall Patricia Hemingway	Director	Feb 06 '26	Sale	229.72	4,000	918,880	28,264	Feb 10 04:13 PM
Patricia Hemingway Hall	Director	Feb 06 '26	Proposed Sale	229.69	4,000	918,760		Feb 06 04:06 PM
WEITZMAN DEBORAH	Officer	Aug 20 '25	Proposed Sale	150.53	21,367	3,216,330		Aug 20 04:23 PM
WEITZMAN DEBORAH	CEO, PSS Segment	Aug 20 '25	Sale	150.53	21,367	3,216,375	53,428	Aug 20 04:12 PM
Hollar Jason M.	Chief Executive Officer	Aug 20 '25	Sale	150.04	35,901	5,386,566	200,000	Aug 20 04:12 PM
Scherer Mary C.	Chief Accounting Officer	Aug 19 '25	Sale	149.25	6,766	1,009,826	3,556	Aug 19 07:22 PM
Greene Michelle D.	Chief Information Officer	Aug 19 '25	Sale	148.82	13,500	2,009,043	14,976	Aug 19 07:21 PM
Mason Stephen M	CEO, GMPD Segment	Aug 19 '25	Sale	148.82	41,575	6,187,064	26,085	Aug 19 07:20 PM
Hollar Jason M.	Chief Executive Officer	Aug 19 '25	Sale	148.90	107,705	16,037,649	235,901	Aug 19 07:19 PM
Mayer Jessica L	Chief Legal/Compliance Officer	Aug 19 '25	Sale	148.82	38,078	5,666,833	48,457	Aug 19 07:19 PM
Alt Aaron E	Chief Financial Officer	Aug 19 '25	Sale	148.78	48,243	7,177,389	30,650	Aug 19 07:18 PM
Snow Ola M	Chief Human Resources Officer	Aug 19 '25	Sale	148.94	28,151	4,192,917	15,431	Aug 19 07:17 PM
Alt Aaron E	Officer	Aug 19 '25	Proposed Sale	148.87	42,870	6,382,024		Aug 19 05:22 PM
Hollar Jason M.	Officer	Aug 19 '25	Proposed Sale	149.02	143,606	21,400,000		Aug 19 05:21 PM
Snow Ola M	Officer	Aug 19 '25	Proposed Sale	166.71	25,151	4,192,926		Aug 19 05:20 PM
Mayer Jessica L	Officer	Aug 19 '25	Proposed Sale	148.82	38,078	5,666,934		Aug 19 05:20 PM
Mason Stephen M	Officer	Aug 19 '25	Proposed Sale	148.81	41,575	6,186,923		Aug 19 05:18 PM
Alt Aaron E	Officer	Aug 19 '25	Proposed Sale	148.00	5,373	795,204		Aug 19 03:45 PM
Greene Michelle D.	Officer	Aug 19 '25	Proposed Sale	148.82	13,500	2,009,030		Aug 19 02:50 PM

MCK

Mckesson Corp

COR

Cencora Inc

COSM

Cosmos Health Inc

HLF

Herbalife Ltd

NUS

Nu Skin Enterprises Inc

CAH

Cardinal Health Inc

Upgrade your Finviz experience